Once the anatomical characteristics of the models have been described, the goal is to develop an RP model by targeting known mechanisms of RP pathophysiology of primary and secondary RP, such as endothelin-1 and vascular endothelial growth factor (VEGF), among others. Here, VEGFA is linked to retinitis pigmentosa 1.